Avantium (Netherlands) a commercial-stage clinical research organization focused on high-throughput R&D, closed a $36.2M Series B financing. Participants include Sofinnova Partners, Aster Capital, De Hoge Dennen, Aescap Venture, Capricorn Cleantech Fund, ING Corporate Investments and Navitas Capital.

The 2Q11 OnBioVC Trend Analysis will be published on Tue 6 September. Advertising opportunities are still available. Reach >45,000 high-value targeted life science professionals on-line and in-print. Contact arubenstein@rnaventures.com for details.